Data / Form D filings / Arda Therapeutics, Inc.
Arda Therapeutics, Inc.: Form D filings
Arda Therapeutics, Inc., a biotechnology company in San Carlos, CA, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on October 2, 2024, reports $43.3 million sold of a $43.4 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 930 Brittan Ave, San Carlos, CA, 94070
- Phone
- (650) 804-8953
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1903317
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | New notice | $43,438,362 | $43,303,366 | $134,996 | 17 | Sep 16, 2024 | sec.gov |
| Jan 14, 2022 | New notice | $8,499,996 | $7,499,998 | $999,998 | 10 | Dec 17, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vineeta Agarwala | Director | |
| Adam Freund | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 30, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Arda Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.